HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$2.16
+0.02 (+0.93%)
Open$2.10
Previous Close$2.14
Day High$2.16
Day Low$1.99
52W High$18.60
52W Low$1.75
Volume—
Avg Volume8.6K
Market Cap15.16M
P/E Ratio—
EPS$-12.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+785.2% upside
Current
$2.16
$2.16
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.04M | 3.40M | 5.84M |
| Net Income | -33,323,974 | -98,236,412 | 1.21M |
| Profit Margin | -3,209.8% | -3,049.3% | 20.8% |
| EBITDA | -33,903,704 | -105,497,932 | 1.81M |
| Free Cash Flow | — | — | 575.3K |
| Rev Growth | -69.5% | -69.5% | -9.0% |
| Debt/Equity | — | — | 0.79 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |